1 completed, 1 recruiting, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow DEB - Dystrophic Epidermolysis Bullosa: new trials by email Literature Review of DEB - Dystrophic Epidermolysis Bullosa trials Research Report on DEB - Dystrophic Epidermolysis Bullosa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa KB803, Placebo - Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa | Phase 3 | Recruiting | Krystal Biotech, Inc. | 16 | 2025-06-20 | 2026-03-12 |
| A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa Open Label Topical Beremagene Geperpavec (B-VEC) - Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa | Phase 3 | Completed | Krystal Biotech, Inc. | 47 | 2021-05-25 | 2024-04-09 |
| The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB) Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa | Withdrawn | Krystal Biotech, Inc. | 2020-01-01 | 2021-09-17 |
Epidermolysis Bullosa Dystrophica (3) · Corneal Injuries (1)
Collagen Diseases (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Connective Tissue Diseases (3) · Epidermolysis Bullosa (3) · Genetic Diseases, Inborn (3) · Skin Abnormalities (3) · Skin Diseases (3) · Skin Diseases, Genetic (3) · Skin Diseases, Vesiculobullous (3) · Skin and Connective Tissue Diseases (3) · Corneal Diseases (1) · Craniocerebral Trauma (1) · Eye Diseases (1) · Eye Injuries (1)
United States (3)
David Chien, MD (1)